TPG regains Aptalis unit from Actavis

Private equity firm TPG will acquire Aptalis Pharmaceutical Technologies, a pharmaceutical outsourcing and R&D

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE